Verum Partners LLC Takes Position in Philip Morris International Inc. (NYSE:PM)

Verum Partners LLC bought a new stake in Philip Morris International Inc. (NYSE:PM - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 1,427 shares of the company's stock, valued at approximately $227,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. NewSquare Capital LLC grew its holdings in Philip Morris International by 53.7% in the 4th quarter. NewSquare Capital LLC now owns 206 shares of the company's stock valued at $25,000 after buying an additional 72 shares in the last quarter. Pacifica Partners Inc. raised its holdings in Philip Morris International by 115.0% in the first quarter. Pacifica Partners Inc. now owns 215 shares of the company's stock valued at $35,000 after acquiring an additional 115 shares in the last quarter. Ameriflex Group Inc. acquired a new stake in Philip Morris International during the fourth quarter worth approximately $36,000. McClarren Financial Advisors Inc. acquired a new stake in Philip Morris International during the fourth quarter worth approximately $33,000. Finally, Knuff & Co LLC purchased a new position in shares of Philip Morris International during the fourth quarter worth approximately $36,000. Hedge funds and other institutional investors own 78.63% of the company's stock.

Analysts Set New Price Targets

PM has been the subject of several research reports. Bank of America lifted their price target on Philip Morris International from $182.00 to $200.00 and gave the stock a "buy" rating in a research note on Wednesday. Stifel Nicolaus upped their target price on Philip Morris International from $168.00 to $186.00 and gave the company a "buy" rating in a research report on Thursday, April 24th. Needham & Company LLC assumed coverage on Philip Morris International in a research report on Thursday, May 22nd. They set a "buy" rating on the stock. UBS Group raised Philip Morris International from a "sell" rating to a "neutral" rating and raised their price target for the company from $130.00 to $170.00 in a report on Friday, April 25th. Finally, Morgan Stanley reaffirmed an "overweight" rating and set a $182.00 target price (up previously from $156.00) on shares of Philip Morris International in a research note on Thursday, April 24th. Two investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $175.30.

Philip Morris International Trading Down 0.1%

PM traded down $0.19 on Friday, reaching $181.77. The stock had a trading volume of 2,646,970 shares, compared to its average volume of 5,616,502. Philip Morris International Inc. has a fifty-two week low of $98.93 and a fifty-two week high of $183.94. The company has a market capitalization of $282.93 billion, a price-to-earnings ratio of 40.30, a price-to-earnings-growth ratio of 2.65 and a beta of 0.52. The firm has a 50-day moving average of $167.81 and a 200-day moving average of $147.58.

Philip Morris International (NYSE:PM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $1.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.61 by $0.08. Philip Morris International had a negative return on equity of 120.08% and a net margin of 7.89%. The business had revenue of $9.30 billion for the quarter, compared to analyst estimates of $9.10 billion. During the same quarter in the prior year, the company earned $1.50 earnings per share. The company's quarterly revenue was up 5.8% on a year-over-year basis. Sell-side analysts anticipate that Philip Morris International Inc. will post 7.14 EPS for the current fiscal year.

Philip Morris International Profile

Philip Morris International Inc operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches.